My previous post, “MS Drugs Offer Hope, But Can You Afford Them?” addressed the concerns of patients who require high-priced prescription drugs for treatment of multiple sclerosis or other chronic conditions. This crisis, once relegated to the uninsured and the underinsured, is now being felt by patients with group medical coverage.
Reaction to a recent article in the New York Times, “Co-payments Soar for Drugs with High Prices,” has been widespread. Newspaper columnists and bloggers...

